Myla Lai-Goldman, M.D.

Myla Lai-Goldman, M.D.

DirectoratQuanterix· In proxies 2024–2025

Myla Lai-Goldman, M.D. sits on 7 public boards.

Boards1

  • QuanterixDirector · 0 yr on the boardIndependentNominating and Governance—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. QuanterixPublic company · 2 yr
    • Director2024 – Present · 2 yrStock in role -89%
  2. Mercy BioAnalytics, Inc.Public company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  3. NovoPath Inc.Public company · 4 yr
    • Director2022 – Present · 4 yrNo stock prices for these years
  4. Vigil Neuroscience, Inc.Public company · 6 yr
    • Director2020 – Present · 6 yrNo stock prices for these years
  5. West PharmaceuticalPublic company · 12 yr
    • Director2014 – Present · 12 yrNo stock prices for these years
  6. GeneCentric Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  7. Akoya BiosciencesPublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?